Summary. Susceptibilities to cefotaxime (Ctx) and ceftazidime (Caz) were examined for 90 recent clinical isolates of Enterobacter cloacae from Greek hospitals. Most (68%) of the isolates were resistant to both drugs, and all were resistant to cefoxitin. P-Lactamase activities against cephaloridine in crude extracts from Ctx-Caz-resistant isolates were high, irrespective of whether or not the cells were grown with cefoxitin as an inducer of the chromosomal p-lactamase, indicating stable derepression of the gene for the enzyme. On the other hand, double disk antagonism tests showed that all the Ctx-Caz-sensitive isolates possessed inducible expression of this P-lactamase. Iso-electric focusing revealed the presence of five forms of the chromosomal P-lactamase, randomly distributed amongst the Ctx-Cazresistant and -sensitive isolates. Plasmid-mediated P-lactamases of TEM and PSE types also were found in many isolates. These data indicate that the extremely high prevalence of CtxCaz-resistant E. cloacae isolates in Greek hospitals is attributed to the dissemination of mutants which constitutively overproduce the class-I chromosomal P-lactamase. Over 90 % of these isolates exhibited cross-resistance to aminoglycosides, suggesting the accumulation of unrelated antibiotic resistance mechanisms. 
Introduction
The introduction of newer cephalosporins such as cefotaxime and ceftazidime has improved the potential for effective treatment in serious infections caused by gram-negative pathogens. However, the clinical use of these antimicrobial agents was followed rapidly by the emergence of resistance in several species, including Enterobacter cloacae. Several studies have shown that cephalosporin resistance in E. cloacae is due mainly to the overproduction (" stable derepression ") of the class-I P-lactamase encoded by the chromosomal ampC gene.'. Stably derepressed mutants are segregated from inducible strains at relatively high freq~encies.~ Therapeutic failures witk cephalosporin treatment have been associated with the selection and ultimate dominance of these variants. 4 9 Combination therapy with a cephalosporin plus an aminoglycoside is often employed to prevent development of resistance.
Hospitals in the Athens area have recorded an alarming frequency of isolation of E. cloacae strains highly resistant to aminoglycosides and to cefotaxime and ceftazidime (unpublished data). The present study Received was undertaken to obtain further information on the extent and the nature of this phenomenon.
Materials and methods

Bacterial isolates
A total of 90 randomly selected, non-replicate clinical isolates of E. cloacae from separate patients was examined. They were collected from various clinical specimens, mainly of urine and sputum, from 12 hospitals in the Greater Athens area; 60 isolates were from four major hospitals (1 1-20 isolates per hospital) and 30 isolates were from eight minor units (1-7 isolates per hospital). All were from patients with active infection. The bacteria were identified by the API 20E System (API BioMerieux, La Balme Les Grottes, France).
Antibiotic susceptibility tests
Antibiotic susceptibilities of the isolates were determined in Mueller-Hinton Broth (Oxoid) by a microdilution technique. An inoculum of lo4 cfu/ml was used and the isolates were considered to be resistant or sensitive according to the recom-mendations of the Working Party of the British Society for Antimicrobial Chemotherapy.' On this basis, cefotaxime and ceftazidime resistances were defined as MIC > 1 and > 2 mg/L, respectively.
Detect ion of inducible P-lac tamases
Screening for inducible Q-lactamase production was by the cefoxitin diffusion method.' Inducer disks containing 10 pg of cefoxitin (AB Biodisc, Solna, Sweden) were used in combination with disks containing 30 pg of cefotaxime and 30 pg of ceftazidime (Oxoid).
Extraction of P-lactamases
Sonic extracts of cultures grown for 6 h in Trypticase Soya Broth (Oxoid) were used for the detection of P-lactamases and for hydrolysis studies. The protein content of the extracts was measured by the BioRad Protein Assay kit (BioRad Laboratories, Richmond, CA, USA).
Induction of P-lactamases
Induction of 8-lactamases was investigated as follows : the organisms were incubated overnight at 37°C in Trypticase Soya Broth, and 1 ml of each culture was transferred into 9 ml of the same broth. After 90min, cefoxitin was added to a final concentration of 50 mg/L. Incubation was continued for 4 h, after which the P-lactamase was released by sonic treatment.
Hydrolytic studies
P-Lactamase hydrolysis rates were studied by a UV spectrophotometric method, as previously described,' with cephaloridine (Glaxo, Greenford) as the substrate. The cephaloridine solution was prepared in 0.1 M phosphate buffer (pH 7.0) at a final concentration of 1 mM, and hydrolysis was measured at 37°C in 3-ml cuvettes, at a wavelength of 295 nm. Results were expressed as units of hydrolytic activity (1 unit = 1 nmol of antibiotic hydrolysed/min/mg of protein) .
Analytical iso-electric focusing (IEF)
IEF was performed on polyacrylamide gels as described elsewhere. lo P-Lactamases were visualised by overlying gels with filter paper moistened with a solution of nitrocefin (Oxoid) 0.5 mg/ml in 0.1 M sodium phosphate buffer (pH 7.0) containing dimethylosulphoxide 1 YO v/v. In some experiments, the focused gels were flooded with a 1 mM potassium clavulanate solution before the application of nitrocefin. This allowed the in-situ distinction between class I and plasmid-mediated enzymes, as the latter, but not the former, are inhibited by clavulanate." Cefoxitin disk diffusion tests revealed that all the Ctx-Caz-sensitive isolates possessed inducible /I-lactamases. The test was not applicable to the Ctx-Caz resistant isolates, because none of them gave a substantial inhibition zone around a disk containing one of the third generation cephalosporins. In quantitative assays, it was found that growth in the presence of cefoxitin strongly induced cephaloridine-hydrolysing activity in all the Ctx-Caz-sensitive isolates. Uninduced P-lactamase activities ranged from 10 to 80 units, but in all cases exceeded the 3000 units after induction with cefoxitin. High levels of P-lactamase activity against cephaloridine ( > 1000 units) were found in crude extracts of all the Ctx-Caz-resistant isolates, even when the cultures were grown without induction with cefoxitin. This finding, taken together with their Ctx-Caz-resistance phenotype, indicates that these isolates were hyperproducers of chromosomal /I-lactamases. Interestingly, substantial differences in inducibility were observed amongst these suggests that, in some cases, derepression was not total. Iso-electric focusing revealed the production of five forms of the chromosomal p-lactamase, with isoelectric points (PIS) ranging from 8.0 to 9.2 (table 111, figure).
Fifty-six (62 YO) of the isolates also possessed one or more secondary p-lactamases, with PIS of 5.4 (53 % of the isolates), 5.6 (7 YO), 6-1 (4 %) and 6.9 (8 %). These secondary enzymes were presumably plasmidmediated, and were inhibited in situ by flooding the focused gels with clavulanate solution. The occurrence of these p-lactamases did not correlate with resistance to Ctx and Caz. Also, hydrolysis rates from crude extracts of isolates possessing such enzymes did not differ significantly from the rates observed with isolates that had chromosomal enzymes only. Thus, it is suggested that the distortion in the measurements of plactamase activity caused by the presence of secondary enzymes was negligible. drugs and the development of clinically important E. cloacae infections has also been r e p~r t e d .~~ It has been reported that most (70-80%) clinical isolates of E. cloacae possess inducible class-I chromosomal P-lactamases.*7 14* l5 These isolates are resistant to cefoxitin but susceptible to third-generation cephalosporins such as cefotaxime and ceftazidime. The remaining isolates are either stably derepressed producers of the class-I enzymes and are resistant to virtually all p-lactams, or are basal producers, susceptible to most p-lactam drugs including cefoxitin. l6
Third-generation cephalosporins are poor inducers of the class-I enzymes but remain labile to their hydrolytic action. Moreover, these /I-lactamases exhibit high affinity for the newer cephalosporins, a fact which facilitates their hydrolytic activity in the periplasmic space. l' Therefore, derepressed but not inducible cells express resistance and the compounds can select such variants more readily than other p- In contrast with the above reports, we found that most of the isolates tested in the present study (68 %) were stably derepressed and so were resistant to both cefotaxime and ceftazidime. These data clearly indicate an unusually high incidence of stably derepressed variants of E. cloacae in Greek hospitals. On the other hand, basal producers of class-I enzymes were not detected. It should be mentioned that decreased outer-membrane permeability in E. cloacae isolates may play an important synergic role in the expression of high levels of resistance to cephalosporins21 and we cannot discount its possible contribution in some of the isolates.
The diversity of different PI forms of class-I plactamase is of academic rather than of clinical interest, since the isolates show a similar spectrum of resistance irrespective of which enzyme-subtype they produce. l6 However, the high incidence of secondary p-lactamases observed is of interest. Enzymes with PIS of 5.4 and 5.6 were found most commonly. These almost certainly correspond to TEM-1 and TEM-2 p-lacta-mases, respectively. These enzymes can confer resistance to carboxy-and ureido-penicillins, expanding the resistance of chromosomal /I-lactamase inducible E. cloacae strains. More rarely, enzymes with PIS of 6.1 and 6-9 were found; these may have been PSE-2 and PSE-3, respectively.
As well as a high frequency of Ctx-Caz resistance among the isolates tested, a similarly high frequency of aminoglycoside resistance was also evident. Moreover, aminoglycoside resistant isolates were significantly more often resistant to cefotaxime and ceftazidime than were aminoglycoside susceptible ones, indicating a linkage of the two resistance phenotypes. In further studies on aminoglycoside resistance in the same E. cloacae collection, various transferable plasmids carrying genes for more than one aminoglycosidemodifying enzyme were found. Detailed typing showed that most of the isolates were epidemiologically distinct (unpublished data).
The high frequency of resistant gram-negative bacilli in Greek hospitals is documented,22 but the degree of cross-resistance and the mechanisms involved have not yet been fully assessed. In previous studies, it was shown that the high frequency of isolation of multiresistant Pseudomas aeruginosa in Greek hospitals was due to the dissemination of a single train,^^.^^ whereas resistance of Klebsiella pneumoniae and E. coli to newer cephalosporins and aminoglycosides resulted from the spread of plasm id^.^^ In contrast to these reports, it seems that simultaneous resistance to newer cephalosporins and aminoglycosides in the E. cloacae strains isolated is due to the occurrence of two genetically unrelated mechanisms, one chromosomal and the other plasmid-mediated.
Infections due to multiresistant E. cloacae are difficult to treat. Nevertheless, imipenem and quinolones retained their activity and could serve as alternatives. However, the accumulation of unrelated resistance mechanisms within the same bacterial population is of special interest and poses a serious problem which is difficult to confront. 26 The data presented here clearly suggest the need for a continuous and detailed surveillance on susceptibility trends in order to formulate effective antibiotic policies in Greek hospitals.
